Cannabis Research
Why Cannabis Regulators Outperform Alcohol Agencies
Add MyCannabis.com to your preferred sources on Google
The content on MyCannabis.com is for educational purposes only and should not be taken as medical advice.
Cannabis vs. Alcohol Regulators: Who Prioritizes Public Health?
The recent analysis, published in the International Journal of Drug Policy, examined annual reports from cannabis and alcohol regulatory agencies across the United States. The researchers wanted to see how these government bodies view their own jobs: are they there to protect public health, or just to collect taxes and bust rule-breakers?
The results were stark. When researchers looked at agency mission statements, 68% of cannabis regulators explicitly prioritized public health goals, compared to only 35% of alcohol regulators.
While alcohol agencies often view themselves as revenue collectors or enforcers of licensing rules, cannabis agencies are far more likely to engage in active public health efforts, such as youth prevention campaigns and data collection on consumption trends.
This discrepancy is what researchers call “ironic.” Alcohol is a leading cause of preventable death in the U.S., linked to liver cirrhosis, traffic fatalities, and addiction. Yet, the agencies governing it are often described as having undergone “regulatory capture”—meaning they may be too cozy with the industry they are supposed to police. Cannabis regulators, perhaps because they are born from a controversial “prohibition” era, feel a stronger burden of proof to demonstrate they are keeping the public safe.
The “California Sober” Shift
This regulatory difference matters immensely because the way Americans consume intoxicants is fundamentally shifting. We are witnessing the rise of the “California Sober” lifestyle—where consumers, particularly young adults, are swapping cocktails for cannabis.
Recent consumer surveys2 and industry reports show more Americans—especially younger adults—are cutting back on alcohol and turning to cannabis instead, often describing it as a one-to-one substitute for drinks in social settings. This isn’t just about smoking; the market has exploded with THC-infused beverages. Unlike the “pot brownies” of the past, which took hours to kick in, these new drinks use nano-emulsion technology to mimic the onset time of alcohol (15–20 minutes), allowing for a social buzz without the hangover or caloric load of beer and wine.
If consumers are moving away from alcohol toward cannabis, it is encouraging that cannabis regulators are paying closer attention to health outcomes. However, the study notes that alcohol agencies’ lack of health focus is a missed opportunity, especially given the physical toll alcohol takes on the body.
The Liver Connection: A Case for Healthier Regulation
The divergence in regulatory focus becomes even more striking when we look at the biological impacts of alcohol and cannabis. Alcohol is well established as hepatotoxic—it damages the liver, increasing the risk of fatty liver, fibrosis, cirrhosis, and ultimately liver failure.
[Image of healthy liver vs cirrhotic liver comparison]
Separate medical research3, including a 2025 propensity-matched cohort study of people with Alcohol Use Disorder (AUD), has found that those who also used cannabis—especially heavy, diagnosed use—had markedly better liver outcomes. Compared to AUD patients who did not use cannabis, they showed a lower risk of developing alcohol-associated liver disease, reduced rates of liver decompensation, and lower all-cause mortality over three years.
Mechanistically, this aligns with what we’re learning about the endocannabinoid system (ECS). Cannabinoid signaling, especially through CB2 and non-intoxicating compounds like CBD, appears to reduce inflammation, oxidative stress, and fat accumulation in the liver, all of which contribute to alcohol-related liver damage.
None of this makes cannabis a “liver supplement,” and recreational use is not a prescribed treatment. But it underlines the irony: the substance with the highest proven burden of organ damage—alcohol—is often managed by regulators who barely reference public health, while a potentially less harmful substance with emerging hepatoprotective research—cannabis—is regulated under a far stricter, health-forward regime.
The “Legislative” Surprise
One of the most significant insights from the study concerns how legalization occurs. You might assume that laws passed by voters (ballot initiatives) would be the most progressive. Surprisingly, the study found the opposite.
States that legalized cannabis through state legislatures (politicians writing laws) produced regulatory agencies that were significantly more focused on public health than states that legalized via ballot measures (citizens voting yes/no).
- Legislative States: 88% of agencies articulated public health goals.
- Ballot States: Only 57% of agencies did the same.
Why? When citizens vote on a ballot, the law is often written by advocacy groups like the “Marijuana Policy Project,” whose primary goal is to open the market, not necessarily to build a robust public health infrastructure. When legislatures write the laws, they have more time to debate, amend, and build in safety guardrails and data monitoring from day one.
Swipe to scroll →
| Indicator | Ballot States | Legislative States |
|---|---|---|
| Public Health Goals Articulated | 57% | 88% |
| Public Health Data Collaboration | 29% | 50% |
| Agency Public Health Efforts | 43% | 50% |
| Law Enforcement Collaboration | 64% | 63% |
Why Regulators Still Rely More on Police Than Public Health Data
Despite cannabis agencies scoring better on health goals, both industries have a blind spot: they still rely too heavily on the police.
The study found that both alcohol and cannabis regulators are far more likely to collaborate with law enforcement than with public health departments.
- 70% of alcohol agencies collaborate with law enforcement.
- 64% of cannabis agencies collaborate with law enforcement.
- But only 36% of cannabis agencies report collaborating with public health agencies for data.
This means that when regulators want to know “how it’s going,” they are looking at arrest records (DUIs, sales to minors) rather than hospital admissions, addiction rates, or demographic health trends. As the authors note, relying on police data is “reactive”—it only catches problems after laws are broken. Public health data is “proactive”—it helps identify trends like Cannabis Use Disorder (CUD) or youth consumption patterns before they become crises.
Conclusion: Flipping the Script
The slogan “Regulate like alcohol” was a successful political tool, but it is a poor policy goal. As we move into a future where THC beverages sit on shelves next to IPAs, and where “California Sober” becomes a common demographic descriptor, we need regulators to evolve.
The findings suggest we shouldn’t be trying to lower cannabis standards to match alcohol’s lax, revenue-focused approach. Instead, we should be asking why alcohol regulators aren’t rising to meet the public health standards currently being set by the cannabis industry. With cannabis agencies acting as the new vanguard for consumer safety, it may be time to update the slogan to: “Regulate alcohol like cannabis.”
References:
1. Carr, C. J., Reuter, P., & Midgette, G. (2025). Public health orientation of Cannabis and alcohol regulators: An analysis of state-level variation in the United States. International Journal of Drug Policy, 146, 105060. https://doi.org/10.1016/j.drugpo.2025.105060
2. Subbaraman, M. S., Kerr, W. C., & Kerr, D. (2025). Oregon adults’ cannabis and alcohol use associations with local cannabis retail access, 2014–2022. American Journal of Preventive Medicine, 69(6), 101142. https://doi.org/10.1016/j.amepre.2025.108164
3. B. Fakhoury, V. Jahagirdar, K. Rama, et al., “The Cannabinoid System as a Potential Novel Target for Alcohol-Associated Liver Disease: A Propensity-Matched Cohort Study,” Liver International 45, no. 11 (2025): e70401, https://doi.org/10.1111/liv.70401.
